| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5394868 (Pediatric) | ORGANON LLC | Inhalation device for powdered medicaments |
Dec, 2012
(11 years ago) | |
| US6949532 | ORGANON LLC | Use of mometasone furoate for treating airway passage and lung diseases |
Jan, 2014
(10 years ago) | |
| US6677322 | ORGANON LLC | Use of mometasone furoate for treating airway passage and lung diseases |
Jan, 2014
(10 years ago) | |
| US5889015 | ORGANON LLC | Use of mometasone furoate for treating lower airway passage and lung diseases |
Jan, 2014
(10 years ago) | |
| US6365581 | ORGANON LLC | Use of mometasone furoate for treating airway passage and lung diseases |
Jan, 2014
(10 years ago) | |
| US6057307 | ORGANON LLC | Use of mometasone furoate for treating airway passage and lung diseases |
Jan, 2014
(10 years ago) | |
|
US6949532 (Pediatric) | ORGANON LLC | Use of mometasone furoate for treating airway passage and lung diseases |
Jul, 2014
(9 years ago) | |
|
US6365581 (Pediatric) | ORGANON LLC | Use of mometasone furoate for treating airway passage and lung diseases |
Jul, 2014
(9 years ago) | |
|
US6677322 (Pediatric) | ORGANON LLC | Use of mometasone furoate for treating airway passage and lung diseases |
Jul, 2014
(9 years ago) | |
|
US6057307 (Pediatric) | ORGANON LLC | Use of mometasone furoate for treating airway passage and lung diseases |
Jul, 2014
(9 years ago) | |
|
US5889015 (Pediatric) | ORGANON LLC | Use of mometasone furoate for treating lower airway passage and lung diseases |
Jul, 2014
(9 years ago) | |
| US5687710 | ORGANON LLC | Inhaler for powdered medications having spiral deagglomeration chamber |
Nov, 2014
(9 years ago) | |
|
US5687710 (Pediatric) | ORGANON LLC | Inhaler for powdered medications having spiral deagglomeration chamber |
May, 2015
(8 years ago) | |
| US5829434 | ORGANON LLC | Inhaler for powdered medications |
Nov, 2015
(8 years ago) | |
|
US5829434 (Pediatric) | ORGANON LLC | Inhaler for powdered medications |
May, 2016
(8 years ago) | |
| US6240918 | ORGANON LLC | Powdered medication inhaler |
Feb, 2017
(7 years ago) | |
|
US6240918 (Pediatric) | ORGANON LLC | Powdered medication inhaler |
Aug, 2017
(6 years ago) | |
| US8173172 | ORGANON LLC | Preparation of powder agglomerates |
Mar, 2018
(6 years ago) | |
| US6503537 | ORGANON LLC | Preparation of powder agglomerates |
Mar, 2018
(6 years ago) | |
|
US8173172 (Pediatric) | ORGANON LLC | Preparation of powder agglomerates |
Sep, 2018
(5 years ago) | |
|
US6503537 (Pediatric) | ORGANON LLC | Preparation of powder agglomerates |
Sep, 2018
(5 years ago) | |
Asmanex Twisthaler is owned by Organon Llc.
Asmanex Twisthaler contains Mometasone Furoate.
Asmanex Twisthaler has a total of 21 drug patents out of which 21 drug patents have expired.
Expired drug patents of Asmanex Twisthaler are:
- US5394868*PED
- US6949532
- US6677322
- US5889015
- US6365581
- US6057307
- US6949532*PED
- US6365581*PED
- US6677322*PED
- US6057307*PED
- US5889015*PED
- US5687710
- US5687710*PED
- US5829434
- US5829434*PED
- US6240918
- US6240918*PED
- US8173172
- US6503537
- US8173172*PED
- US6503537*PED
Asmanex Twisthaler was authorised for market use on 01 February, 2008.
Asmanex Twisthaler is available in powder;inhalation dosage forms.
Asmanex Twisthaler can be used as treatment of asthma.
The generics of Asmanex Twisthaler are possible to be released after 17 September, 2018.
Drugs and Companies using MOMETASONE FUROATE ingredient
Market Authorisation Date: 01 February, 2008
Treatment: Treatment of asthma
Dosage: POWDER;INHALATION
ASMANEX TWISTHALER family patents
